Fumio Takada

1.5k total citations
33 papers, 624 citations indexed

About

Fumio Takada is a scholar working on Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Fumio Takada has authored 33 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Fumio Takada's work include BRCA gene mutations in cancer (5 papers), Connective tissue disorders research (5 papers) and Prenatal Screening and Diagnostics (4 papers). Fumio Takada is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Connective tissue disorders research (5 papers) and Prenatal Screening and Diagnostics (4 papers). Fumio Takada collaborates with scholars based in Japan, United States and Canada. Fumio Takada's co-authors include Michiyuki Kawakami, Yoshinaga Takayama, Yoshimitsu Fukushima, Hiromi Hatsuse, Shiro Ikegawa, Aki Takahashi, Minoru Isomura, Yusuke Nakamura, Susan T. Iannaccone and Carina Wallgren‐Pettersson and has published in prestigious journals such as The Journal of Immunology, Neurology and Annals of Neurology.

In The Last Decade

Fumio Takada

29 papers receiving 613 citations

Peers

Fumio Takada
David F. LePage United States
Gillian Borland United Kingdom
Jana Královičová United Kingdom
Mary R. Dusing United States
Karen L. Yager United States
M.Q. Islam Sweden
SM Greenberg United States
David F. LePage United States
Fumio Takada
Citations per year, relative to Fumio Takada Fumio Takada (= 1×) peers David F. LePage

Countries citing papers authored by Fumio Takada

Since Specialization
Citations

This map shows the geographic impact of Fumio Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Takada more than expected).

Fields of papers citing papers by Fumio Takada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Takada. The network helps show where Fumio Takada may publish in the future.

Co-authorship network of co-authors of Fumio Takada

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Takada. A scholar is included among the top collaborators of Fumio Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Takada. Fumio Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waraya, Mina, Takafumi Sangai, Ryo Kawata, et al.. (2025). Hidden SVA retrotransposon insertion in BRCA1 revealed by nanopore targeted sequencing causes hereditary breast and ovarian cancer. Journal of Human Genetics. 70(10). 503–508.
2.
Arai, Yasuhiro, Shin‐ya Nishio, Shinichi Goto, et al.. (2025). Novel OTOG Variants and Clinical Features of Hearing Loss in a Large Japanese Cohort. Genes. 16(1). 60–60.
3.
Okamura, Ken, T. Saito, Fumio Takada, et al.. (2025). Deep intronic variant in TYR causes OCA1A in Japanese families through pseudoexon activation. Journal of Dermatological Science. 120(2). 77–79.
5.
Migita, Ohsuke, et al.. (2021). A novel TAB2 mutation detected in a putative case of frontometaphyseal dysplasia. Human Genome Variation. 8(1). 40–40. 2 indexed citations
6.
Ogata‐Kawata, Hiroko, A. Sasaki, Ken Takahashi, et al.. (2021). Improved library preparation protocols for amplicon sequencing-based noninvasive fetal genotyping for RHD-positive D antigen-negative alleles. BMC Research Notes. 14(1). 380–380. 1 indexed citations
7.
Sasaki, A., Shigehito Yamada, Hidehiko Miyake, et al.. (2018). Current status of prenatal diagnosis in Japan 1998-2016. 54(1). 101–107. 7 indexed citations
8.
Suzuki, Yoshiro, David Chitayat, Hirotake Sawada, et al.. (2018). TRPV6 Variants Interfere with Maternal-Fetal Calcium Transport through the Placenta and Cause Transient Neonatal Hyperparathyroidism. The American Journal of Human Genetics. 102(6). 1104–1114. 54 indexed citations
9.
Migita, Ohsuke, Tomoko Kawai, K. Okamura, et al.. (2018). Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome. European Journal of Medical Genetics. 62(9). 103547–103547. 13 indexed citations
10.
Miyake, Hidehiko, Shigehito Yamada, Yosuke Fujii, et al.. (2016). Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in Japan. Journal of Human Genetics. 61(10). 879–884. 4 indexed citations
11.
Narumi, Yoko, Sachiko Nishina, Yoko Aoki, et al.. (2014). Identification of a novel missense mutation of MAF in a Japanese family with congenital cataract by whole exome sequencing: A clinical report and review of literature. American Journal of Medical Genetics Part A. 164(5). 1272–1276. 28 indexed citations
13.
Muto, Kaori, et al.. (2009). Problems in the Regulation of Genetic Tests in Japan: What Can We Learn from Direct-to-Consumer Genetic Tests. Public Health Genomics. 13(6). 327–335. 3 indexed citations
14.
Ando, N, Yukiko Saito, Kazuhisa Takemura, Fumio Takada, & Yumi Iwamitsu. (2008). Knowledge and impressions regarding the concept of mutation among Japanese university students. Clinical Genetics. 74(1). 75–81. 3 indexed citations
15.
Nishimura, Akira, Haruya Sakai, Shiro Ikegawa, et al.. (2007). FBN2, FBN1, TGFBR1, and TGFBR2 analyses in congenital contractural arachnodactyly. American Journal of Medical Genetics Part A. 143A(7). 694–698. 21 indexed citations
16.
Yoshida, Kunihiro, Haruya Sakai, Haruka Hamanoue, et al.. (2006). A −16C>T substitution in the 5′ UTR of the puratrophin-1 gene is prevalent in autosomal dominant cerebellar ataxia in Nagano. Journal of Human Genetics. 51(5). 461–466. 23 indexed citations
17.
Niihori, Tetsuya, Yoko Aoki, Hirofumi Ohashi, et al.. (2005). Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia. Journal of Human Genetics. 50(4). 192–202. 87 indexed citations
18.
Ikegawa, Shiro, Yoshimitsu Fukushima, Minoru Isomura, Fumio Takada, & Yusuke Nakamura. (1995). Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Human Genetics. 96(3). 309–11. 48 indexed citations
19.
Takayama, Yoshinaga, Fumio Takada, Aki Takahashi, & Michiyuki Kawakami. (1994). A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s.. The Journal of Immunology. 152(5). 2308–2316. 42 indexed citations
20.
Takada, Fumio, Yoshinaga Takayama, Hiromi Hatsuse, & Michiyuki Kawakami. (1993). A New Member of the C1s Family of Complement Proteins Found in a Bactericidal Factor, Ra-Reactive Factor, in Human Serum. Biochemical and Biophysical Research Communications. 196(2). 1003–1009. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026